tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market
INBX
Inhibrx Biosciences Inc
RESEARCH TOOLSreports
Want to see INBX full AI Analyst Report?

Inhibrx Biosciences Inc (INBX) Ratios

72 Followers

Inhibrx Biosciences Inc Ratios

INBX's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, INBX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.93 3.93 3.94 5.25 10.17
Quick Ratio
 3.93 3.93 3.94 5.25 10.17
Cash Ratio
 3.68 3.68 3.75 4.94 9.93
Solvency Ratio
 -0.99 -0.99 35.81 -0.91 -0.62
Operating Cash Flow Ratio
 -3.84 -3.84 -4.77 -3.43 -4.18
Short-Term Operating Cash Flow Coverage
 -55.80 -55.80 -121.89 0.00 -61.99
Net Current Asset Value
$ -5.65M$ -5.65M$ 113.22M$ 30.97M$ 47.67M
Leverage Ratios
Debt-to-Assets Ratio
 0.73 0.73 0.04 0.68 0.71
Debt-to-Equity Ratio
 13.39 13.39 0.06 4.83 3.57
Debt-to-Capital Ratio
 0.93 0.93 0.06 0.83 0.78
Long-Term Debt-to-Capital Ratio
 0.93 0.93 0.00 0.83 0.78
Financial Leverage Ratio
 18.33 18.33 1.35 7.08 5.01
Debt Service Coverage Ratio
 -8.72 -9.13 112.91 -6.49 -7.00
Interest Coverage Ratio
 -11.07 -11.07 -24.57 -6.89 -8.02
Debt to Market Cap
 0.05 0.08 <0.01 0.12 0.21
Interest Debt Per Share
 7.70 7.70 1.49 5.13 5.57
Net Debt to EBITDA
 0.14 0.13 -0.08 0.33 0.53
Profitability Margins
Gross Profit Margin
-91.00%-91.00%-1042.50%33.83%-4926.73%
EBIT Margin
-9933.15%-10386.54%850532.50%-11549.11%-5795.71%
EBITDA Margin
-9742.23%-10195.54%851675.00%-11482.94%-5739.83%
Operating Profit Margin
-10386.54%-10386.54%-165724.00%-12178.94%-5890.37%
Pretax Profit Margin
-10773.31%-10773.31%843787.00%-13318.00%-6625.14%
Net Profit Margin
-10773.46%-10773.46%843786.00%-13408.94%-6625.27%
Continuous Operations Profit Margin
-10773.46%-10773.46%843786.00%-13318.17%-6625.27%
Net Income Per EBT
100.00%100.00%100.00%100.68%100.00%
EBT Per EBIT
103.72%103.72%-509.15%109.35%112.47%
Return on Assets (ROA)
-95.62%-95.62%933.56%-78.39%-49.93%
Return on Equity (ROE)
-269.56%-1752.22%1263.30%-554.81%-250.14%
Return on Capital Employed (ROCE)
-119.83%-119.83%-236.69%-87.14%-49.04%
Return on Invested Capital (ROIC)
-117.41%-117.41%-234.02%-86.43%-48.69%
Return on Tangible Assets
-95.62%-95.62%933.56%-78.39%-49.93%
Earnings Yield
-7.02%-11.45%757.00%-13.48%-14.70%
Efficiency Ratios
Receivables Turnover
 7.34 7.34 0.48 2.31 8.53
Payables Turnover
 0.42 0.42 0.25 0.11 13.23
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.14 0.14 0.01 0.19 0.30
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 0.01 0.01 <0.01 <0.01 0.01
Cash Conversion Cycle
 -824.07 -824.07 -710.27 -3.20K 15.21
Days of Sales Outstanding
 49.70 49.70 766.50 157.76 42.79
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 873.77 873.77 1.48K 3.36K 27.58
Operating Cycle
 49.70 49.70 766.50 157.76 42.79
Cash Flow Ratios
Operating Cash Flow Per Share
 -8.38 -8.38 -13.43 -4.10 -2.87
Free Cash Flow Per Share
 -8.38 -8.38 -13.61 -4.20 -2.89
CapEx Per Share
 <0.01 <0.01 0.18 0.10 0.02
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
 -4.19K -4.19K -13.05 -42.09 -168.08
Capital Expenditure Coverage Ratio
 -4.19K -4.19K -74.86 -42.09 -168.08
Operating Cash Flow Coverage Ratio
 -1.21 -1.21 -24.16 -0.92 -0.56
Operating Cash Flow to Sales Ratio
 -99.84 -99.84 -972.04 -107.39 -52.60
Free Cash Flow Yield
-6.90%-10.61%-88.37%-11.05%-11.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -14.24 -8.74 0.13 -7.42 -6.80
Price-to-Sales (P/S) Ratio
 1.45K 941.13 1.11K 994.97 450.85
Price-to-Book (P/B) Ratio
 249.54 153.07 1.67 41.17 17.02
Price-to-Free Cash Flow (P/FCF) Ratio
 -14.49 -9.42 -1.13 -9.05 -8.52
Price-to-Operating Cash Flow Ratio
 -15.37 -9.43 -1.15 -9.26 -8.57
Price-to-Earnings Growth (PEG) Ratio
 0.13 0.08 >-0.01 -0.18 -0.10
Price-to-Fair Value
 249.54 153.07 1.67 41.17 17.02
Enterprise Value Multiple
 -14.72 -9.10 0.05 -8.34 -7.32
Enterprise Value
 1.86B 1.21B 78.38M 1.72B 921.50M
EV to EBITDA
 -14.72 -9.10 0.05 -8.34 -7.32
EV to Sales
 1.43K 927.90 391.90 957.31 420.39
EV to Free Cash Flow
 -14.36 -9.29 -0.40 -8.71 -7.94
EV to Operating Cash Flow
 -14.36 -9.29 -0.40 -8.91 -7.99
Tangible Book Value Per Share
 0.52 0.52 9.23 0.92 1.45
Shareholders’ Equity Per Share
 0.52 0.52 9.23 0.92 1.45
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 <0.01 >-0.01 >-0.01
Revenue Per Share
 0.08 0.08 0.01 0.04 0.05
Net Income Per Share
 -9.04 -9.04 116.58 -5.12 -3.62
Tax Burden
 1.00 1.00 1.00 1.01 1.00
Interest Burden
 1.08 1.04 0.99 1.15 1.14
Research & Development to Revenue
 86.50 86.94 1.02K 105.92 50.27
SG&A to Revenue
 17.91 17.92 639.52 16.32 9.64
Stock-Based Compensation to Revenue
 8.57 8.57 292.59 13.80 9.33
Income Quality
 0.93 0.93 -0.12 0.81 0.79
Currency in USD